In the presence of several types of pharmaceutical compounds (including CDK4/6i) to inhibit mitosis, paclitaxel was observed to induce micronucleation, suggesting a non-mitotic mechanism to break up the cancer nucleus (59, 68). The gene discussed is CDK4; the disease is cancer.